Verve Therapeutics Inc (VERV)
5.965
-0.42
(-6.50%)
USD |
NASDAQ |
May 17, 16:00
5.965
0.00 (0.00%)
After-Hours: 20:00
Verve Therapeutics Price: 5.965 for May 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 17, 2024 | 6.33 | 6.34 | 5.900 | 5.98 | 2.186M |
May 16, 2024 | 6.77 | 6.77 | 6.32 | 6.38 | 2.138M |
May 15, 2024 | 6.47 | 6.62 | 6.12 | 6.23 | 1.255M |
May 14, 2024 | 6.51 | 6.83 | 6.13 | 6.23 | 1.494M |
May 13, 2024 | 6.14 | 6.83 | 6.10 | 6.22 | 1.723M |
May 10, 2024 | 6.32 | 6.43 | 5.88 | 6.01 | 1.605M |
May 09, 2024 | 6.13 | 6.725 | 6.13 | 6.36 | 1.956M |
May 08, 2024 | 6.13 | 6.29 | 5.99 | 6.08 | 1.464M |
May 07, 2024 | 6.46 | 6.46 | 6.04 | 6.16 | 888521.0 |
May 06, 2024 | 6.50 | 6.725 | 6.28 | 6.41 | 812274.0 |
May 03, 2024 | 6.43 | 7.00 | 6.28 | 6.41 | 1.395M |
May 02, 2024 | 6.13 | 6.25 | 6.00 | 6.15 | 949617.0 |
May 01, 2024 | 6.04 | 6.56 | 5.84 | 6.00 | 1.765M |
Apr 30, 2024 | 6.09 | 6.315 | 5.958 | 6.01 | 1.022M |
Apr 29, 2024 | 6.25 | 6.55 | 6.11 | 6.26 | 933216.0 |
Apr 26, 2024 | 6.26 | 6.409 | 6.02 | 6.16 | 791566.0 |
Apr 25, 2024 | 6.28 | 6.35 | 6.05 | 6.22 | 1.221M |
Apr 24, 2024 | 6.87 | 6.92 | 6.525 | 6.58 | 1.004M |
Apr 23, 2024 | 6.90 | 7.41 | 6.81 | 6.88 | 965009.0 |
Apr 22, 2024 | 6.75 | 7.03 | 6.46 | 6.91 | 909065.0 |
Apr 19, 2024 | 6.59 | 6.80 | 6.42 | 6.64 | 1.098M |
Apr 18, 2024 | 6.70 | 6.86 | 6.53 | 6.66 | 1.247M |
Apr 17, 2024 | 7.23 | 7.27 | 6.72 | 6.74 | 1.155M |
Apr 16, 2024 | 7.15 | 7.264 | 7.03 | 7.14 | 691055.0 |
Apr 15, 2024 | 7.73 | 7.73 | 7.13 | 7.31 | 1.369M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.965
Minimum
May 17 2024
73.99
Maximum
Sep 10 2021
25.05
Average
19.83
Median
Apr 07 2022
Price Benchmarks
Acorda Therapeutics Inc | 0.605 |
Eli Lilly and Co | 770.00 |
Beam Therapeutics Inc | 24.73 |
Gritstone Bio Inc | 0.7826 |
Prime Medicine Inc | 7.085 |
Price Related Metrics
PS Ratio | 27.04 |
Price to Book Value | 0.8612 |
Earnings Yield | -47.99% |
Market Cap | 502.11M |